OBR Daily Commentary

forumImage

Controversy Heats Up Over Pharmacy Benefit Manager DIR Fees

(COA) Nov 8, 2017 - Pharmacy benefits managers (PBMs) are in hot water again if small and specialty pharmacies’ voices can be heard.

Read Article arrow

Dean Gesme, MD (Posted: November 08, 2017)

quotesDIR fees represent an egregious, morally indefensible and obscure business practice that will push PBMs to the edge of ethical and legal acceptability for patients, providers, regulators, and legislators. Be forewarned!quotes

Add Comment 1 Comment
forumImage

Exercise Interventions In Advanced Lung Cancer Patients Led To Increased Functionality, Which May Be Linked To Quality Of Life Benefits

(WCLC) Oct 18, 2017 - Physical exercise and psycho-social interventions in patients with advanced stage lung cancer improved functional capacity, which may be linked to quality of life benefits.

Read Article arrow

Dean Gesme, MD (Posted: October 18, 2017)

quotesRehabilitation and Pre-habilitation are woefully underutilized by oncologists as adjuncts to the treatments which we prescribe. Patients deserve the opportunity to optimize their physical wellbeing in order to maximize quality of life and minimize treatment related toxicities.quotes

Add Comment 1 Comment
forumImage

Obinutuzumab vs Rituximab in FL: 'Too Close to Call’

(Medscape Medical News) Oct 4, 2017 - Obinutuzumab for induction and maintenance provides significantly higher PFS than rituximab, the current standard of care for follicular lymphoma (FL). But an editorial cautions it's too soon to tell.

Read Article arrow

Dean Gesme, MD (Posted: October 05, 2017)

quotesAn excellent editorial this past week in JCO authored by Jim Armitage and Dan Longo on this important topic.quotes

Add Comment 1 Comment

Meet the Editorial Board

Community Oncology
member photo
Dean Gesme, MD

FACP FACPE FASCO President, Minnesota Oncology...

Breast Cancer
member photo
Debu Tripathy, MD

Professor and Chair, Department of Breast Medical Oncol...

Lung Cancer
member photo
H. Jack West, MD

Medical Director, Thoracic Oncology Program, Swedish Ca...

Gastrointestinal Cancers
member photo
Howard S. Hochster, MD

Associate Cancer Center Director, Yale Cancer Center P...

Radiation Oncology
member photo
Howard Sandler, MD, MS, FASTRO

Ronald H. Bloom Chair in Cancer Therapeutics
Pr...

Community Oncology
member photo
Jeff Patton, M.D.

CEO Tennessee Oncology...

Precision Medicine Section Editor
member photo
Jennifer Levin Carter, MD, MPH

Chief Medical Officer and Founder, N-of-One...

Financial Sector
member photo
Michael G. King Jr.

Managing Director and Senior Biotechnology Analyst...

Gastrointestinal Cancers
member photo
Richard Goldberg, MD

Director WVU Cancer Institute Director of Cancer Signa...

Editor-In-Chief
member photo
Robert A. Figlin, MD., FACP

Professor and Director, Division of Hematology Oncology...

Health Policy
member photo
Ted Okon

Executive Director Community Oncology Alliance...

Community Oncology
member photo
Thomas Marsland, MD

Vice President Integrated Community Oncology Network ...

Community Oncology
member photo
William Harwin MD

Florida Cancer Specialists President and Managing Part...

Health Policy
member photo
William McGivney, PhD

National Health Policy Expert...

Payer
member photo
Winston Wong, PharmD

President, W-Squared Group...